Charles River Laboratories International, Inc.
CRLFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Charles River Laboratories International, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 18 annual periods. The latest annual period ends Dec 27, 2025. The latest insider filing shown is dated Jun 8, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Ranger Investment Management, L.P. | 2026-03-31 | 70,715 | $12.2M | SEC filing |
| Federation des caisses Desjardins du Quebec | 2026-03-31 | 3,116 | $537K | SEC filing |
| CHOREO, LLC | 2026-03-31 | 2,208 | $381K | SEC filing |
| HighTower Advisors, LLC | 2026-03-31 | 3,578 | $617K | SEC filing |
| CANADA PENSION PLAN INVESTMENT BOARD | 2026-03-31 | 4,000 | $690K | SEC filing |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2026-03-31 | 1,125,143 | Not shown | SEC filing |
| Annis Gardner Whiting Capital Advisors, LLC | 2026-03-31 | 86 | $14.8K | SEC filing |
| Mirae Asset Global Investments Co., Ltd. | 2026-03-31 | 9,992 | $1.72M | SEC filing |
| BANCO BILBAO VIZCAYA ARGENTARIA, S.A. | 2026-03-31 | 13,762 | $2.37M | SEC filing |
| Creative Planning | 2026-03-31 | 17,028 | $2.94M | SEC filing |
| Dunhill Financial, LLC | 2026-03-31 | 1 | Not shown | SEC filing |
| PRINCIPAL SECURITIES, INC. | 2026-03-31 | 6,500 | $1.12M | SEC filing |
| Norinchukin Bank, The | 2026-03-31 | 2,813 | $485K | SEC filing |
| Rossby Financial, LCC | 2026-03-31 | 35 | $6.12K | SEC filing |
| JOHNSON INVESTMENT COUNSEL INC | 2026-03-31 | 26,640 | $4.6M | SEC filing |
| Longaeva Partners L.P. | 2026-03-31 | 36,721 | $6.33M | SEC filing |
| Byrne Asset Management LLC | 2026-03-31 | 38 | $6.56K | SEC filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2026-03-31 | 1,305,694 | $225M | SEC filing |
| AQR CAPITAL MANAGEMENT LLC | 2026-03-31 | 71,578 | $11.8M | SEC filing |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 2026-03-31 | 3,400 | $587K | SEC filing |
- Each value is checked against Charles River Laboratories International, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at Charles River Laboratories International, Inc.'s share price.
- Value not shown for 1 row: the value per share could not be confirmed against the share prices on file from within three months of the report date.
120 filers have only one report here.
Independent insiders buying near the same time
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-03-03 | LaPlume Joseph W · EVP, Corp Strategy & Develop | Common Stock | P — Open market or private purchase | +25 | 174.54 | SEC filing |
| 2025-08-22 | LaPlume Joseph W · EVP, Corp Strategy & Develop | Common Stock | S — Open market or private sale | −400 | 163.72 | SEC filing |
| 2025-08-18 | LaPlume Joseph W · EVP, Corp Strategy & Develop | Common Stock | S — Open market or private sale | −800 | 157.60 | SEC filing |
| 2025-08-07 | LaPlume Joseph W · EVP, Corp Strategy & Develop | Common Stock | S — Open market or private sale | −400 | 150.04 | SEC filing |
| 2025-05-15 | MASSARO GEORGE · Director | Common Stock | S — Open market or private sale | −24 | 139.05 | SEC filing |
| 2025-05-15 | MASSARO GEORGE · Director | Common Stock | S — Open market or private sale | −81 | 137.68 | SEC filing |
| 2025-05-15 | MASSARO GEORGE · Director | Common Stock | S — Open market or private sale | −35 | 136.32 | SEC filing |
| 2025-05-14 | MASSARO GEORGE · Director | Common Stock | S — Open market or private sale | −7 | 143.77 | SEC filing |
Showing 8 of 13 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-05 | Parisotto Shannon M · CEVP, Disc & Safety Assessment | Common Stock | G — Bona fide gift | +1,529 | SEC filing |
| 2026-06-05 | FOSTER JAMES C · Director | Common Stock | G — Bona fide gift | −20,000 | SEC filing |
| 2026-06-05 | Parisotto Shannon M · CEVP, Disc & Safety Assessment | Common Stock | G — Bona fide gift | −1,529 | SEC filing |
| 2026-06-05 | FOSTER JAMES C · Director | Common Stock | G — Bona fide gift | −10,000 | SEC filing |
| 2026-06-05 | Girshick Birgit · Chief Executive Officer | Common Stock | G — Bona fide gift | +3,386 | SEC filing |
| 2026-06-05 | FOSTER JAMES C · Director | Common Stock | G — Bona fide gift | +153,361 | SEC filing |
| 2026-06-05 | FOSTER JAMES C · Director | Common Stock | G — Bona fide gift | +10,000 | SEC filing |
| 2026-06-05 | Girshick Birgit · Chief Executive Officer | Common Stock | G — Bona fide gift | −3,386 | SEC filing |
Showing 8 of 32 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.